LVW Advisors LLC Grows Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• LVW Advisors LLC increased its stake in HCA Healthcare, Inc. by 21.9% during the second quarter, acquiring an additional 653 shares and making its holdings worth approximately $1.39 million.
• HCA Healthcare reported earnings of $6.84 per share, exceeding analysts' expectations of $6.20, alongside a revenue increase of 6.4% year-over-year to $18.61 billion.
• The company announced a quarterly dividend of $0.72 per share, reflecting a 0.7% yield and a dividend payout ratio of 12.11%.

LVW Advisors LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 21.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,639 shares of the company's stock after acquiring an additional 653 shares during the period. LVW Advisors LLC's holdings in HCA Healthcare were worth $1,394,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Signaturefd LLC lifted its position in HCA Healthcare by 442.0% in the second quarter. Signaturefd LLC now owns 17,446 shares of the company's stock valued at $6,684,000 after acquiring an additional 14,227 shares during the last quarter. ORG Partners LLC lifted its position in HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company's stock valued at $55,000 after acquiring an additional 31 shares during the last quarter. Patton Fund Management Inc. purchased a new stake in shares of HCA Healthcare in the second quarter valued at about $257,000. Kathmere Capital Management LLC raised its holdings in shares of HCA Healthcare by 63.6% in the second quarter. Kathmere Capital Management LLC now owns 1,376 shares of the company's stock valued at $527,000 after buying an additional 535 shares during the last quarter. Finally, Destiny Wealth Partners LLC raised its holdings in shares of HCA Healthcare by 3.1% in the second quarter. Destiny Wealth Partners LLC now owns 2,335 shares of the company's stock valued at $895,000 after buying an additional 70 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 1.2%

Shares of HCA opened at $419.77 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The firm's 50-day moving average is $389.80 and its two-hundred day moving average is $368.78. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $422.46. The firm has a market capitalization of $98.22 billion, a P/E ratio of 17.64, a PEG ratio of 1.30 and a beta of 1.41.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period in the prior year, the business posted $5.50 earnings per share. The firm's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on HCA. Wolfe Research cut shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Cantor Fitzgerald reiterated an "overweight" rating and set a $444.00 price target on shares of HCA Healthcare in a research note on Tuesday, August 26th. Morgan Stanley dropped their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research note on Monday, July 28th. Finally, Robert W. Baird boosted their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $407.75.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.